A significant breakthrough in cancer study is arising with the use of VHH fragments to reactivate damaged p53. This essential cancer inhibitor protein is frequently lost in several types of tumors, resulting https://bookmarkextent.com/story24145594/mini-antibodies-revive-tumor-suppressor-p53-the-new-pathway-for-cancer-therapy